ACE and heart failure: In the work presented here we explored the proteome and phosphoproteome changes associated with a model of heart failure, and define for the first time global changes resulting from treatment with β-AR blocker (metoprolol) and ACE inhibitor (enalapril) in HFrEF hearts as well as in control hearts.